These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 31983727)
1. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke - ANAFIE Registry. Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K; Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727 [TBL] [Abstract][Full Text] [Related]
2. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF ( Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385 [TBL] [Abstract][Full Text] [Related]
3. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack. Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012 [TBL] [Abstract][Full Text] [Related]
4. Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry. Yoshimoto T; Toyoda K; Ihara M; Inoue H; Yamashita T; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Maruyama H; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T Stroke; 2022 Aug; 53(8):2549-2558. PubMed ID: 35440169 [TBL] [Abstract][Full Text] [Related]
5. Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan - Insight From the ANAFIE (All Nippon AF In Elderly) Registry. Hiasa KI; Kaku H; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Ikeda T; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Tsutsui H Circ J; 2020 Feb; 84(3):388-396. PubMed ID: 31969518 [TBL] [Abstract][Full Text] [Related]
6. Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study. Yasaka M; Umeyama M; Kataoka H; Inoue H J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105034. PubMed ID: 32807446 [TBL] [Abstract][Full Text] [Related]
7. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation. Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143 [TBL] [Abstract][Full Text] [Related]
8. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study. Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488 [TBL] [Abstract][Full Text] [Related]
9. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013 [TBL] [Abstract][Full Text] [Related]
10. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation. Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191 [TBL] [Abstract][Full Text] [Related]
11. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry. Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y; Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591 [TBL] [Abstract][Full Text] [Related]
12. Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program. Yasaka M; Uchiyama S; Atarashi H; Okumura K; Koretsune Y; Yamashita T; Taniguchi A; Fukaya T; Inoue H; J Stroke Cerebrovasc Dis; 2020 May; 29(5):104717. PubMed ID: 32113736 [TBL] [Abstract][Full Text] [Related]
13. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729 [TBL] [Abstract][Full Text] [Related]
14. Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region - Analysis Using the National Health Insurance Database. Narita N; Okumura K; Kinjo T; Mikami J; Tsushima K; Takahashi R; Noro M; Hashimoto A; Sasaki T; Takaki M; Ishidoya E; Narita Y; Imai H; Ono E; Tomita H Circ J; 2020 Apr; 84(5):706-713. PubMed ID: 32213724 [TBL] [Abstract][Full Text] [Related]
15. Residual Stroke Risk in Patients with Atrial Fibrillation Treated with Non-Vitamin K Oral Anticoagulants: An 8-Year Retrospective Cohort Study. Szeto CLC; Hui KF Cerebrovasc Dis Extra; 2021; 11(1):9-14. PubMed ID: 33461208 [TBL] [Abstract][Full Text] [Related]
16. Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry. Yamashiro K; Tanaka R; Miyazaki S; Miyauchi K; Hayashi H; Nishizaki Y; Nojiri S; Suwa S; Sumiyosi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106871. PubMed ID: 36356431 [TBL] [Abstract][Full Text] [Related]
17. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge. Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W; Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967 [TBL] [Abstract][Full Text] [Related]
18. Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation. Kitazono T; Ikeda T; Ogawa S; Nakagawara J; Minematsu K; Miyamoto S; Murakawa Y; Cavaliere M; Hayashi Y; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S Heart Vessels; 2020 Mar; 35(3):399-408. PubMed ID: 31492970 [TBL] [Abstract][Full Text] [Related]
19. A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry). Okumura K; Yamashita T; Suzuki S; Akao M; Clin Cardiol; 2020 Mar; 43(3):251-259. PubMed ID: 31737921 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]